An international clinical trial found that new drug aficamten boosts exercise capacity and quality of life for obstructive hypertrophic cardiomyopathy patients.
Clinical trial: New drug makes exercise, everyday tasks easier for people with common heart condition medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.
SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.